{
  "sector": "Healthcare",
  "fullTimeEmployees": 429,
  "longBusinessSummary": "CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides; and DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. It also develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; TB Booster for the BCG-vaccinated population; and Ad5-nCov, a recombinant novel coronavirus disease vaccine. In addition, the company is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB105 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. It has a collaboration with The National Research Council of Canada to advance vaccine against COVID-19; and co-development agreement with Precision NanoSystems, Inc. to develop a mRNA lipid nanoparticle vaccine against COVID-19. CanSino Biologics Inc. was founded in 2009 and is headquartered in Tianjin, the People's Republic of China.",
  "city": "Tianjin",
  "phone": "86 22 5821 3600",
  "country": "China",
  "companyOfficers": [],
  "website": "http://www.cansinotech.com",
  "maxAge": 1,
  "address1": "401-420, Biomedical Park",
  "fax": "86 22 5821 3677",
  "industry": "Drug Manufacturersâ€”Specialty & Generic",
  "address2": "4th Floor 185 South Avenue TEDA West District",
  "previousClose": 28.1,
  "regularMarketOpen": 29.26,
  "twoHundredDayAverage": 26.13875,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 29.27,
  "navPrice": null,
  "averageDailyVolume10Day": 9112,
  "totalAssets": null,
  "regularMarketPreviousClose": 28.1,
  "fiftyDayAverage": 26.13875,
  "trailingAnnualDividendRate": null,
  "open": 29.26,
  "averageVolume10days": 9112,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": null,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 29.26,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 12973,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 10741680128,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 9112,
  "priceToSalesTrailing12Months": null,
  "dayLow": 29.26,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 12973,
  "fiftyTwoWeekHigh": 29.27,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 22.6,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 29.27,
  "exchange": "PNK",
  "shortName": "CANSINO BIOLOGICS INC",
  "longName": "CanSino Biologics Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "CASBF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_108945349",
  "uuid": "380a74d7-49df-3aa4-a750-db436ab6cd84",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 132671000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.45859,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.26077998,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 140427818,
  "enterpriseValue": 6953341952,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 29.26,
  "logo_url": "https://logo.clearbit.com/cansinotech.com"
}